Syndax Pharmaceuticals Logo

Syndax Pharmaceuticals

🇺🇸
SNDX
US87164F1057

Syndax Pharmaceuticals is a US-based biopharmaceutical company specializing in the development of innovative cancer therapies. It focuses on researching targeted oncology drugs to improve treatment options for patients living with leukemia and various types of solid tumors.

Next Quarterly Earnings

Thursday, October 29, 2026
CW 44
After-Hours
In 63 days

After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

Quiet period starts on October 1, 2026

Stock Price

Frequently asked questions

When will Syndax Pharmaceuticals report its next quarterly earnings?

Syndax Pharmaceuticals is scheduled to report its next quarterly earnings on 10/29/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).

When did Syndax Pharmaceuticals last report quarterly earnings?

Syndax Pharmaceuticals last reported quarterly earnings on 8/4/2026 (Q2 2026). Earnings per share (EPS) came in at -0.55 USD.

How often has Syndax Pharmaceuticals beaten expectations?

Syndax Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).

How do I add the Syndax Pharmaceuticals earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:-$0.46
Actual:
Q2 2026
Missed
Estimate:-$0.45
Actual:-$0.55
Difference:-$0.10
Price reaction (1 day):+4.4 %
Price reaction (7 days):+6.3 %
Q1 2026
Beat
Estimate:-$0.62
Actual:-$0.48
Difference:+$0.14
Price reaction (1 day):-10.8 %
Price reaction (7 days):-4.2 %
Q3 2025
Missed
Estimate:-$0.58
Actual:-$0.78
Difference:-$0.20
Q2 2025
Beat
Estimate:-$0.71
Actual:-$0.70
Difference:+$0.01
Q1 2025
Beat
Estimate:-$1.01
Actual:-$0.83
Difference:+$0.18

Earnings statistics

Estimates vs. results

3/5
Quarters above estimates
60%
Beat rate
-0.1%
Avg. EPS surprise

Basis: 5 quarters with an analyst estimate and reported EPS.

Past price reactions are not a reliable indicator of future performance.

Company Information

Name
Syndax Pharmaceuticals
Ticker Symbol
SNDX
ISIN
US87164F1057
Country
🇺🇸
USA
Sector